Principal Financial Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.56M | Sell |
|
|||||
|
2025
Q2 | $6.48M | Buy |
|
|||||
|
2025
Q1 | $6.64M | Buy |
|
|||||
|
2024
Q4 | $4.86M | Buy |
|
|||||
|
2024
Q3 | $3.72M | Sell |
|
|||||
|
2024
Q2 | $7.35M | Sell |
|
|||||
|
2024
Q1 | $7.76M | Buy |
|
|||||
|
2023
Q4 | $8.87M | Sell |
|
|||||
|
2023
Q3 | $8.09M | Sell |
|
|||||
|
2023
Q2 | $10.9M | Sell |
|
|||||
|
2023
Q1 | $11.6M | Sell |
|
|||||
|
2022
Q4 | $11.3M | Sell |
|
|||||
|
2022
Q3 | $16.3M | Sell |
|
|||||
|
2022
Q2 | $20.2M | Buy |
|
|||||
|
2022
Q1 | $26.1M | Sell |
|
|||||
|
2021
Q4 | $21.8M | Sell |
|
|||||
|
2021
Q3 | $22M | Buy |
|
|||||
|
2021
Q2 | $23.6M | Sell |
|
|||||
|
2021
Q1 | $28.3M | Buy |
|
|||||
|
2020
Q4 | $23.7M | Sell |
|
|||||
|
2020
Q3 | $25.3M | Buy |
|
|||||
|
2020
Q2 | $20.1M | Buy |
|
|||||
|
2020
Q1 | $12.5M | Sell |
|
|||||
|
2019
Q4 | $17.5M | Buy |
|
|||||
|
2019
Q3 | $14.2M | Buy |
|
|||||
|
2019
Q2 | $1.75M | Buy |
|
|||||
|
2019
Q1 | $490K | Buy |
|
|||||
|
2018
Q4 | $515K | Sell |
|
|||||
|
2018
Q3 | $594K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $226K | Sell |
|
|||||
|
2017
Q4 | $512K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $261K | Buy |
|
|||||
|
2017
Q1 | $237K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $258K | Sell |
|
|||||
|
2015
Q4 | $483K | Hold |
|
|||||
|
2015
Q3 | $258K | Buy |
|
|||||
|
2015
Q2 | $444K | Sell |
|
|||||
|
2015
Q1 | $587K | Buy |
|
|||||
|
2014
Q4 | $583K | Sell |
|
|||||
|
2014
Q3 | $737K | Buy |
|
|||||
|
2014
Q2 | $682K | Sell |
|
|||||
|
2014
Q1 | $609K | Sell |
|
|||||
|
2013
Q4 | $505K | Buy |
|
|||||
|
2013
Q3 | $368K | Sell |
|
|||||
|
2013
Q2 | $266K | Buy |
|